The J. M. Smucker 2026 Q2 Earnings Record Net Income Surge of 1084.9%

Generated by AI AgentDaily EarningsReviewed byAInvest News Editorial Team
Tuesday, Nov 25, 2025 8:28 pm ET2min read
Aime RobotAime Summary

- The J. M.

(SJM) reported a 1084.9% net income surge to $241. in Q2 2026, reversing a $24.5M loss, driven by cost discipline and portfolio adjustments.

- Revenue rose 2.6% to $2.33B, with U.S. Retail Coffee ($848.9M) and Pet Foods ($413.2M) leading growth, while EPS jumped to $2.26 from -$0.23.

- Despite 5.9% weekly stock declines and poor post-earnings performance, the company maintained 4% revenue growth guidance and targets 3x net debt/EBITDA by 2027.

- CEO Mark Smucker highlighted momentum in pet treats and Uncrustables (on track for $1B sales) but acknowledged spreads and coffee tariff challenges.

The J. M.

(SJM) delivered a dramatic turnaround in fiscal 2026 Q2, reporting net income of $241.30 million, a 1084.9% increase from a $24.50 million loss in 2025 Q2. The company exceeded expectations with revenue growth of 2.6% and issued in-line guidance, maintaining its 4% reported revenue growth and 3x net debt/EBITDA target for 2027.

Revenue

The J. M. Smucker’s total revenue rose to $2.33 billion in 2026 Q2, a 2.6% increase from $2.27 billion in 2025 Q2. U.S. Retail Coffee led with $848.90 million in revenue, followed by U.S. Retail Frozen Handheld and Spreads contributing $461.10 million. The U.S. Retail Pet Foods segment added $413.20 million, while Sweet Baked Snacks generated $256.10 million. International and Away From Home revenue totaled $350.80 million, rounding out the $2.33 billion performance.

Earnings/Net Income

The company returned to profitability with an EPS of $2.26 in 2026 Q2, reversing a $0.23 loss in 2025 Q2. This 1082.6% positive swing underscores a remarkable turnaround, driven by cost discipline and strategic portfolio adjustments.

Price Action

The stock price of The J. M. Smucker has edged down 0.00% during the latest trading day, has dropped 5.91% during the most recent full trading week, and has edged down 1.72% month-to-date.

Post-Earnings Price Action Review

The strategy of buying The J. M. Smucker (SJM) shares 30 days after the earnings release date resulted in poor performance over the past three years. The strategy had a CAGR of -11.57% with a maximum drawdown of 0.00% and a Sharpe ratio of -0.44, indicating significant underperformance and risk compared to the benchmark, which had a CAGR of 66.23% and a maximum drawdown of 3.73%. The strategy's excess return was -94.75%, further highlighting its ineffectiveness.

CEO Commentary

Mark Smucker highlighted sequential improvement in Sweet Baked Snacks, attributing it to SKU rationalization and relaunched Suzy Q’s. Momentum in pet treats, particularly Milk-Bone’s return to growth, and innovation in Uncrustables, which is on track for $1 billion in sales, were emphasized. Challenges in spreads and coffee tariffs were acknowledged, but confidence in margin recovery in fiscal 2027 was expressed.

Guidance

The company guided to $1 billion in Uncrustables sales by fiscal 2026, low single-digit pet portfolio growth in Q3-Q4, and sequential improvement in Sweet Baked Snacks. Coffee margins are expected to exceed 20% in Q4 2026, with $75 million in tariff-related costs absorbed in Q3. Revenue growth is projected at 4% reported (5.5% comparable), with net debt/EBITDA targeted to decline to 3x by fiscal 2027.

Additional News

The J. M. Smucker announced a quarterly dividend of $1.10 per share, implying a 4.2% annualized yield. Institutional investor Vanguard Group trimmed its stake by 1.1%, reducing ownership to 12.11% of the company. Meanwhile, CFO Tucker Marshall sold 11,139 shares at $108.11, reducing his position by 24.75%. Analysts adjusted price targets, with Morgan Stanley raising its estimate to $118.00 and maintaining an "overweight" rating.

The company’s strategic focus on SKU rationalization, innovation, and margin recovery positions it for long-term growth. Despite near-term challenges in spreads and coffee tariffs, the trajectory for Uncrustables and pet treats suggests resilience. Investors should monitor execution risks and the impact of tariff relief in fiscal 2027.

Comments



Add a public comment...
No comments

No comments yet